Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial
2014 ◽
Vol 16
(2)
◽
pp. 270-280
◽
2018 ◽
Vol Volume 10
◽
pp. 773-790
◽
2014 ◽
Vol 147
(2)
◽
pp. 443-443
◽
2018 ◽
Vol 109
(2)
◽
pp. 303-342
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. e11531-e11531
2016 ◽
Vol 34
(15_suppl)
◽
pp. 567-567
◽